Biomotion Sciences Recorded Big Gain
Tue, Jan 28, 2025 at 07:25 PM
Biomotion Sciences (SLXN:NASDAQ) rocketted at $1.35, representing a gain of 132.8%. On Tue, Jan 28, 2025, SLXN:NASDAQ hit a New 2-Week High of $1.35. The stock got featured on our News Catalysts scanner on Tue, Jan 28, 2025 at 12:57 PM in the 'BIOTECH' category. From Wed, Jan 15, 2025, the stock recorded 25.00% Up Days and 11.11% Green Days
About Biomotion Sciences (SLXN:NASDAQ)
Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 269.23%
- Dunxin Financial Holdings Limited (DXF:NYSEMKT), 168.26%
- Biomotion Sciences (SLXN:NASDAQ), 132.76%
- Trinity Biotech plc (TRIB:NASDAQ), 78.95%
- Planet Image International Limited (YIBO:NASDAQ), 66.88%
- Diginex Limited (DGNX:NASDAQ), 59.13%
- IMAC Holdings Inc. (BACK:NASDAQ), 47.17%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 45.53%
- LatAmGrowth SPAC (LATG:NASDAQ), 40%
- Hepion Pharmaceuticals, Inc. (HEPA:NASDAQ), 34.97%